• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

比较使用和不使用眼科粘弹剂的可植入Collamer 透镜植入的临床结果。

Comparison of clinical outcomes of implantable collamer lens implantation with and without use of an ophthalmic viscosurgical device.

机构信息

From the Onuuri Smile Eye Clinic (Kim), Seoul, Onnuri Eye Hospital (Chung), Jeollabuk-do, South Korea.

出版信息

J Cataract Refract Surg. 2021 Feb 1;47(2):198-203. doi: 10.1097/j.jcrs.0000000000000417.

DOI:10.1097/j.jcrs.0000000000000417
PMID:32925657
Abstract

PURPOSE

To compare the clinical efficacy of posterior chamber phakic implantable collamer lens (ICL) implantation with and without the use of an ophthalmic viscosurgical device (OVD).

SETTING

Onnuri Eye Hospital, Jeonju, Jeollabuk-do, South Korea.

DESIGN

Retrospective case series.

METHODS

Included were patients who underwent ICL implantation with the use of an OVD (OVD group) and patients who underwent ICL implantation without the use of an OVD (hydro group). Refractive error, endothelial cell density (ECD), intraocular pressure (IOP), vault, and adverse events were evaluated at 1 day, 1 week, 1 month, and 3 months postoperatively. The IOP and vault were checked 1 hour postoperatively, and the surgical time was recorded.

RESULTS

The OVD group comprised 54 eyes of 27 patients and the hydro group 49 eyes of 25 patients. There were no significant preoperative differences between the 2 groups. At 1 hour postoperatively, the IOP was significantly higher in the OVD group (P < .001); however, there was no significant difference in IOP between the 2 groups at other follow-up timepoints. Surgical time was significantly shorter for the hydro group (P = .032). There was no statistically significant difference in vault, ECD, or refractive error between the 2 groups during the 3-month follow-up period. No adverse events were observed.

CONCLUSIONS

ICL implantation without the use of an OVD was safe and effective. The advantages of this technique included a short surgical time, prevention of early postoperative IOP spikes, and cost savings due to OVD elimination.

摘要

目的

比较使用和不使用眼用粘弹剂(OVD)行后房型有晶状体眼人工晶状体(ICL)植入的临床疗效。

设置

韩国全罗北道全州 Onnuri 眼科医院。

设计

回顾性病例系列。

方法

纳入使用 OVD(OVD 组)和不使用 OVD(水组)行 ICL 植入的患者。术后 1 天、1 周、1 个月和 3 个月评估屈光不正、内皮细胞密度(ECD)、眼内压(IOP)、拱高和不良事件。术后 1 小时检查 IOP 和拱高,并记录手术时间。

结果

OVD 组 27 例 54 眼,水组 25 例 49 眼。两组患者术前无显著差异。术后 1 小时,OVD 组的 IOP 显著更高(P<0.001);然而,两组在其他随访时间点的 IOP 无显著差异。水组的手术时间显著更短(P=0.032)。在 3 个月的随访期间,两组间的拱高、ECD 或屈光不正无统计学差异。未观察到不良事件。

结论

不使用 OVD 行 ICL 植入是安全有效的。该技术的优点包括手术时间短、预防术后早期 IOP 骤升和因消除 OVD 而节省成本。

相似文献

1
Comparison of clinical outcomes of implantable collamer lens implantation with and without use of an ophthalmic viscosurgical device.比较使用和不使用眼科粘弹剂的可植入Collamer 透镜植入的临床结果。
J Cataract Refract Surg. 2021 Feb 1;47(2):198-203. doi: 10.1097/j.jcrs.0000000000000417.
2
Safety of the Minimum Ophthalmic Viscosurgical Device Technique in Phakic Implantable Collamer Lens Implantation.最小眼用粘弹剂手术设备技术在有晶状体眼可植入 Collamer 透镜植入术中的安全性。
J Refract Surg. 2020 Jan 1;36(1):42-48. doi: 10.3928/1081597X-20191119-02.
3
Clinical outcomes of a modified ophthalmic viscosurgical device-free implantable collamer lens implantation.改良无眼用黏弹剂的可植入 Collamer 透镜植入术的临床结果。
Indian J Ophthalmol. 2024 Sep 1;72(9):1291-1297. doi: 10.4103/IJO.IJO_2859_23. Epub 2024 May 20.
4
A novel ophthalmic viscosurgical device-free phakic intraocular lens implantation makes myopic surgery safer.一种新型的无眼科粘弹剂的有晶状体眼人工晶状体植入术使近视手术更安全。
Eye Vis (Lond). 2020 Apr 7;7:18. doi: 10.1186/s40662-020-00185-4. eCollection 2020.
5
Correction of Myopia and Myopic Astigmatism by Implantation of a Phakic Posterior Chamber Implantable Collamer Lens.通过植入有晶状体后房可植入胶原晶状体矫正近视和近视散光。
Cesk Slov Oftalmol. 2019 Winter;74(4):147-152. doi: 10.31348/2018/1/4-4-2018.
6
Safety of EVO ICL Implantation With an Ophthalmic Viscosurgical Device-Free Technique in the Early 24 h After Surgery.采用无眼科粘弹剂手术技术植入EVO ICL术后24小时内的安全性
Front Med (Lausanne). 2021 Nov 17;8:764653. doi: 10.3389/fmed.2021.764653. eCollection 2021.
7
Clinical observations of EVO-ICL implantation and changes in corneal astigmatism using a modified technique.EVO-ICL 植入术的临床观察及改良技术对角膜散光的影响。
BMC Ophthalmol. 2022 Sep 23;22(1):381. doi: 10.1186/s12886-022-02603-8.
8
Safety of implantable Collamer lens implantation without ophthalmic viscosurgical device: A retrospective cohort study.无眼科粘弹剂植入可植入式Collamer人工晶状体的安全性:一项回顾性队列研究。
Medicine (Baltimore). 2020 Jun 12;99(24):e20691. doi: 10.1097/MD.0000000000020691.
9
Ten-year clinical outcomes after implantation of a posterior chamber phakic intraocular lens for myopia.后房型有晶状体眼人工晶状体植入治疗近视的 10 年临床效果。
J Cataract Refract Surg. 2019 Nov;45(11):1555-1561. doi: 10.1016/j.jcrs.2019.06.015. Epub 2019 Oct 3.
10
Efficacy and Safety of Hole Implantable Collamer Lens in Comparison with Original Implantable Collamer Lens in Patients with Moderate to High Myopia.与原始可植入式角膜胶原晶状体相比,孔型可植入式角膜胶原晶状体治疗中高度近视患者的疗效和安全性
J Med Assoc Thai. 2017 Feb;100 Suppl 1:S48-55.

引用本文的文献

1
Clinical outcomes of a modified ophthalmic viscosurgical device-free implantable collamer lens implantation.改良无眼用黏弹剂的可植入 Collamer 透镜植入术的临床结果。
Indian J Ophthalmol. 2024 Sep 1;72(9):1291-1297. doi: 10.4103/IJO.IJO_2859_23. Epub 2024 May 20.
2
Causes and management strategies for elevated intraocular pressure after implantable collamer lens implantation.可植入式胶原晶状体植入术后眼压升高的原因及管理策略。
Front Med (Lausanne). 2024 Feb 7;11:1351272. doi: 10.3389/fmed.2024.1351272. eCollection 2024.
3
Clinical observations of EVO-ICL implantation and changes in corneal astigmatism using a modified technique.
EVO-ICL 植入术的临床观察及改良技术对角膜散光的影响。
BMC Ophthalmol. 2022 Sep 23;22(1):381. doi: 10.1186/s12886-022-02603-8.
4
Analysis of perioperative problems related to intraocular Implantable Collamer Lens (ICL) implantation.分析与眼内可植入 Collamer 透镜(ICL)植入相关的围手术期问题。
Int Ophthalmol. 2022 Nov;42(11):3625-3641. doi: 10.1007/s10792-022-02355-w. Epub 2022 Jun 22.